Drug Delivery Technologies: Players, products & prospects to 2015

This major 4-volume strategic analysis provides a detailed insight into the current and future market for drug delivery technology.

• VOLUME I: CONTROLLED- RELEASE DELIVERY
• VOLUME II: NANO-ENABLED DELIVERY
• VOLUME III: NUCLEIC ACID DELIVERY
• VOLUME IV: TARGETED DELIVERY

• Critical analyses and competitive ratings for major specialist developers
• Unique sales forecasts to 2015 for key current and new products utilising drug delivery technologies
• A comprehensive examination of the 4 major and compelling drug delivery sectors

While pharmaceutical sales have continued to rise steadily during the last five years generating over US$600 billion in 2006, the global drug delivery market has undergone rapid growth from an estimated US$26 billion in 2000 to approximately US$67 billion in 2006.

This market has been driven by a number of factors including:

• Patent expiration of leading brands forcing the pharmaceutical industry to evaluate ways to maximize product life-cycles through new formulations, combinations and repositioning;
• Advances in new delivery technology (microencapsulation and nanotechnology); and
• The development and cost-effective manufacture of new delivery materials (dendrimers, lipid formulations and biodegradable polymers).

Within this market there are a number of areas of advanced drug delivery which have attracted the attention of pharmaceutical industry and the investment community. The dramatic growth of the sector is reflected in the evolution of an array of delivery vehicles and hybrid platforms that are increasingly being used to deliver approved and novel therapeutic agents.